{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:10:03Z","timestamp":1789171803138,"version":"build-2803163510"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Anti-IgLON5 disease forms an interface between neuroinflammation and neurodegeneration and includes clinical phenotypes that are often similar to those of neurodegenerative diseases. An early diagnosis of patients with anti-IgLON5 disease and differentiation from neurodegenerative diseases is necessary and may have therapeutic implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In our small sample size study we investigated oculomotor function as a differentiating factor between anti-IgLON5 disease and neurodegenerative disorders. We examined ocular motor and vestibular function in four patients suffering from anti-IgLON5 disease using video-oculography (VOG) and a computer-controlled rotational chair system (sampling rate 60 Hz) and compared the data with those from ten age-matched patients suffering from progressive supranuclear palsy (PSP) and healthy controls (CON).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients suffering from anti-IgLON5 disease differed from PSP most strikingly in terms of saccade velocity and accuracy, the presence of square wave jerks (SWJ) (anti-IgLON5 0\/4\n                      <jats:italic>vs<\/jats:italic>\n                      . PSP 9\/10) and the clinical finding of supranuclear gaze palsy (anti-IgLON5 1\/4). The presence of nystagmus, analysis of smooth pursuit eye movements, VOR and VOR suppression was reliable to differentiate between the two disease entities. Clear differences in all parameters, although not always significant, were found between all patients and CON.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>We conclude that the use of VOG as a tool for clinical neurophysiological assessment can be helpful in differentiating between patients with PSP and patients with anti-IgLON5 disease. VOG could have particular value in patients with suspected PSP and lack of typical Parkinson\u2019s characteristics. future trials are indispensable to assess the potential of oculomotor function as a biomarker in anti-IgLON5 disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2021.753856","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T13:17:40Z","timestamp":1633007860000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Ocular Motor Abnormalities in Anti-IgLON5 Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Stefan","family":"Macher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Milenkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Zrzavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"H\u00f6ftberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Berger-Sieczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus S.","family":"Rommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical Manifestations of the Anti-IgLON5 Disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.628438","article-title":"IgLON Cell Adhesion Molecules are Shed From the Cell Surface of Cortical Neurons to Promote Neuronal Growth","volume":"290","author":"Sanz","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.01261","article-title":"Diglons are Heterodimeric Proteins Composed of IgLON Subunits, and Diglon-CO Inhibits Neurite Outgrowth From Cerebellar Granule Cells","volume":"117","author":"Reed","year":"2004","journal-title":"J Cell Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological Criteria of Anti-IgLON5-Related Tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol (Berl)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/NXI.0000000000000651","article-title":"Anti-IGLON5 Disease: A New Case Without Neuropathologic Evidence of Brainstem Tauopathy","volume":"7","author":"Erro","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00893","article-title":"Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP)","volume":"14","author":"Alster","year":"2020","journal-title":"Front Neurosci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26987","article-title":"Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26608","article-title":"Dystonia, Lower Limb Stiffness, and Upward Gaze Palsy in a Patient With IgLON5 Antibodies","volume":"31","author":"Br\u00fcggemann","year":"2016","journal-title":"Mov Disord"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2016.09.012","article-title":"Chorea and Parkinsonism Associated With Autoantibodies to IgLON5 and Responsive to Immunotherapy","volume":"15","author":"Haitao","year":"2016","journal-title":"J Neuroimmunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/brain\/awx189","article-title":"Movement Disorders With Neuronal Antibodies: Syndromic Approach, Genetic Parallels and Pathophysiology","volume":"141","author":"Balint","year":"2018","journal-title":"Brain J Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2017.03.002","article-title":"IgLON5 Autoimmunity Tested Negative in Patients With Progressive Supranuclear Palsy and Corticobasal Syndrome","volume":"38","author":"Mangesius","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005859","article-title":"IgLON5: A Case With Predominant Cerebellar Tau Deposits and Leptomeningeal Inflammation","volume":"91","author":"Sch\u00f6berl","year":"2018","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005679","article-title":"IgLON5-Mediated Neurodegeneration is a Differential Diagnosis of CNS Whipple Disease","volume":"90","author":"Morales-Brice\u00f1o","year":"2018","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1212\/NXI.0000000000000385","article-title":"IgLON5 Antibody: Neurological Accompaniments and Outcomes in 20 Patients","volume":"4","author":"Honorat","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B15","volume-title":"The Neurology of Eye Movements","author":"Leigh","year":"1999"},{"key":"B16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A Clinical Approach to Diagnosis of Autoimmune Encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2018.00841\/full","article-title":"Detection Methods for Autoantibodies in Suspected Autoimmune Encephalitis","volume":"9","author":"Ricken","year":"2018","journal-title":"Front Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A Novel non-Rapid-Eye Movement and Rapid-Eye-Movement Parasomnia With Sleep Breathing Disorder Associated With Antibodies to IgLON5: A Case Series, Characterisation of the Antigen, and Post-Mortem Study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-0027-y","article-title":"Differential Diagnostic Value of Eye Movement Recording in PSP-Parkinsonism, Richardson\u2019s Syndrome, and Idiopathic Parkinson\u2019s Disease","volume":"255","author":"Pinkhardt","year":"2008","journal-title":"J Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2012.00088","article-title":"Validation of Mobile Eye-Tracking as Novel and Efficient Means for Differentiating Progressive Supranuclear Palsy From Parkinson\u2019s Disease","volume":"6","author":"Marx","year":"2012","journal-title":"Front Behav Neurosci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2019.15.3.339","article-title":"No Evidence of a Contribution of the Vestibular System to Frequent Falls in Progressive Supranuclear Palsy","volume":"15","author":"Goldschagg","year":"2019","journal-title":"J Clin Neurol Seoul Korea"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-019-0160-1","article-title":"How to Spot Ocular Abnormalities in Progressive Supranuclear Palsy? A Practical Review","volume":"8","author":"Phokaewvarangkul","year":"2019","journal-title":"Transl Neurodegener"},{"key":"B23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","article-title":"Distribution Patterns of Tau Pathology in Progressive Supranuclear Palsy","volume":"140","author":"Kovacs","year":"2020","journal-title":"Acta Neuropathol (Berl)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000121388","article-title":"Different Tau Pathology Pattern in Two Clinical Phenotypes of Progressive Supranuclear Palsy","volume":"5","author":"Jellinger","year":"2008","journal-title":"Neurodegener Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm104","article-title":"Pathological Tau Burden and Distribution Distinguishes Progressive Supranuclear Palsy-Parkinsonism From Richardson\u2019s Syndrome","volume":"130","author":"Williams","year":"2007","journal-title":"Brain J Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3988\/jcn.2020.16.1.37","article-title":"A Cortical Substrate for Square-Wave Jerks in Progressive Supranuclear Palsy","volume":"16","author":"Anagnostou","year":"2020","journal-title":"J Clin Neurol Seoul Korea"},{"key":"B27","article-title":"How Normal are \u2018Normal\u2019 Square Wave Jerks","volume":"30","author":"Shallo-Hoffmann","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B28","article-title":"Normal Square Wave Jerks","volume":"20","author":"Herishanu","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/jnnp.54.7.599","article-title":"Square Wave Jerks in Parkinsonian Syndromes","volume":"54","author":"Rascol","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00180","article-title":"Progressive Supranuclear Palsy\u2014Parkinsonism Predominant (PSP-P)\u2014A Clinical Challenge at the Boundaries of PSP and Parkinson\u2019s Disease (Pd)","volume":"11","author":"Alster","year":"2020","journal-title":"Front Neurol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.51.863","article-title":"[The Diagnosis of Neurodegenerative Disorders Based on Clinical and Pathological Findings Using an MRI Approach]","volume":"51","author":"Watanabe","year":"2011","journal-title":"Rinsho Shinkeigaku"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-010-0563-8","article-title":"In Vivo Comparison of Richardson\u2019s Syndrome and Progressive Supranuclear Palsy-Parkinsonism","volume":"118","author":"Srulijes","year":"2011","journal-title":"J Neural Transm Vienna Austria 1996"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10386-5","article-title":"Bilateral Vestibulopathy in Anti-IgLON5 Disease","volume":"268","author":"Helmchen","year":"2021","journal-title":"J Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.753856\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T13:17:45Z","timestamp":1633007865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.753856\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2021.753856"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.753856","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"article-number":"753856"}}